Vaccine Adjuvants Market Size And Forecast By Type (Pathogen, Adjuvant Emulsion, Particulate), By Route of Administration (Oral, Intradermal, Intranasal, Intramuscular), By Application, And Trend Analysis, 2018 - 2025

Table of Contents

Chapter 1 Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Vaccine Adjuvants Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.1.1 Rise in importance of immunization across the globe
3.2.1.2 High predominance of chronic diseases
3.2.1.3 Technologic advancements in the types of vaccines
3.2.1.4 Other drivers
3.2.2 Market restraint analysis
3.2.2.1 Cost of immunization
3.2.2.2 Lack of healthcare infrastructure
3.3 Penetration & Growth Prospect Mapping
3.4 Vaccine Adjuvants - SWOT Analysis, by Factor (Political & legal, economic, and technological)
3.5 Industry Analysis - Porter’s
Chapter 4 Vaccine Adjuvants Market: Type Estimates & Trend Analysis
4.1 Vaccine Adjuvants Market: Vaccine Type Movement Analysis
4.2 Pathogen
4.2.1 Pathogen market, 2014 - 2025 (USD Million)
4.3 Adjuvant Emulsion
4.3.1 Adjuvant emulsion market, 2014 - 2025 (USD Million)
4.4 Particulate
4.4.1 Particulate market, 2014 - 2025 (USD Million)
4.5 Combination
4.5.1 Combination market, 2014 - 2025 (USD Million)
4.6 Others
4.6.1 Others market, 2014 - 2025 (USD Million)
Chapter 5 Vaccine Adjuvants Market: Application Estimates & Trend Analysis
5.1 Vaccine Adjuvants Market: Application Movement Analysis
5.2 Infectious Diseases
5.2.1 Infectious diseases market, 2014 - 2025 (USD Million)
5.3 Cancer
5.3.1 Cancer market, 2014 - 2025 (USD Million)
5.4 Others
5.4.1 Others market, 2014 - 2025 (USD Million)
Chapter 6 Vaccine Adjuvants Market: Administration Estimates & Trend Analysis
6.1 Vaccine Adjuvants Market: Vaccine Administration Movement Analysis
6.2奥拉l
6.2.1 Oral market, 2014 - 2025 (USD Million)
6.3 Intradermal
6.3.1 Intradermal market, 2014 - 2025 (USD Million)
6.4 Intranasal
6.4.1 Intranasal market, 2014 - 2025 (USD Million)
6.5 Intramuscular
6.5.1 Intramuscular market, 2014 - 2025 (USD Million)
6.6 Others
6.6.1 Others market, 2014 - 2025 (USD Million)
Chapter 7 Vaccine Adjuvants Market: Regional Estimates & Trend Analysis, By Administration, Type & Application
7.1 Vaccine Adjuvants Market: Vaccine Regional Movement Analysis
7.2北美
7.2.1 North America vaccine adjuvants market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.2.2.2 U.S. vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.2.2.3 U.S. vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.2.3.2 Canada vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.2.3.3 Canada vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe vaccine adjuvants market, 2014 - 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.3.2.2 Germany vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.3.2.3 Germany vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
7.3.3 UK
7.3.3.1 UK vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.3.3.2 UK vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.3.3.3 UK vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific vaccine adjuvants market, 2014 - 2025 (USD Million)
7.4.2 China
7.4.2.1 China vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.4.2.2 China vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.4.2.3 China vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
7.4.3 Japan
7.4.3.1 Japan vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.4.3.2 Japan vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.4.3.3 Japan vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America vaccine adjuvants market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.5.2.2 Brazil vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.5.2.3 Brazil vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 MEA vaccine market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
7.6.2.2 South Africa vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
7.6.2.3 South Africa vaccine adjuvants market, by the administration, 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1. GSK
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Novartis/CSL
8.2.2.1. Company overview
8.2.2.2. Product benchmarking
8.2.2.3. Strategic initiatives
8.2.3. Agenus
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Adjuvance
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4 Strategic initiatives
8.2.5. Novavax
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.6. SPI Pharma
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.7. Invivogen
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Avanti Polar Lipids
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.3.9. Brentagg
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 3 North America vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 4 North America vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 5 U.S. vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 6 U.S. vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 7 U.S. vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 8 Canada vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 9 Canada vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 10 Canada vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 11 Europe vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 12 Europe vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 13 Europe vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 14 Germany vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 15 Germany vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 16 Germany vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 17 UK vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 18 UK vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 19 UK vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 21 Asia Pacific vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 22 Asia Pacific vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 23 China vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 24 China vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 25 China vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 26 Japan vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 27 Japan vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 28 Japan vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 29 Latin America vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 30 Latin America vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 31 Latin America vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 32 Brazil vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 33 Brazil vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 34 Brazil vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 35 MEA vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 36 MEA vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 37 MEA vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)
TABLE 38 South Africa vaccine adjuvants market, by type, 2014 - 2025 (USD Million)
TABLE 39 South Africa vaccine adjuvants market, by application, 2014 - 2025 (USD Million)
TABLE 40 South Africa vaccine adjuvants market, by administration, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
图6市场趋势&look
FIG. 7 Market segmentation & scope
FIG. 8 The global vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 9 Market driver relevance analysis (Current & future impact)
FIG. 10 Worldwide immunization coverage: 2014
FIG. 11 Market restrain relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT analysis, by the factor (Political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Vaccine adjuvants market key takeaways
FIG. 16 Vaccine adjuvants market: Application movement analysis
FIG. 17 Global pathogen market, 2014 - 2025 (USD Million)
FIG. 18 Global adjuvant emulsion market, 2014 - 2025 (USD Million)
FIG. 19 Global particulate market, 2014 - 2025 (USD Million)
FIG. 20 Global combination market, 2014 - 2025 (USD Million)
FIG. 21 Global other markets, 2014 - 2025 (USD Million)
FIG. 22 Vaccine adjuvants market application outlook: Key takeaways
FIG. 23 Vaccine adjuvants market: Application movement analysis
FIG. 24 Global infectious diseases market, 2014 - 2025 (USD Million)
FIG. 25 Global cancer market, 2014 - 2025 (USD Million)
FIG. 26 Global other markets, 2014 - 2025 (USD Million)
FIG. 27 Vaccine adjuvants market administration outlook key takeaways
图28疫苗佐剂市场:政府ovement analysis
FIG. 29 Global oral market, 2014 - 2025 (USD Million)
FIG. 30 Global intradermal market, 2014 - 2025 (USD Million)
FIG. 31 Global intranasal market, 2014 - 2025 (USD Million)
FIG. 32 Global intramuscular market, 2014 - 2025 (USD Million)
FIG. 33 Global other markets, 2014 - 2025 (USD Million)
FIG. 34 Regional market place: Key takeaways
FIG. 35 Vaccine market: Regional movement analysis
FIG. 36 North America vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 37 U.S. vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 38 Canada vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 39 Europe vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 40 Germany vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 41 UK vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 42 Asia Pacific vaccine market, 2014 - 2025 (USD Million)
FIG. 43 China vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 44 Japan vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 45 Latin America vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 46 Brazil vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 47 MEA vaccine market, 2014 - 2025 (USD Million)
FIG. 48 South Africa vaccine adjuvants market, 2014 - 2025 (USD Million)
FIG. 49 Strategy framework